2m 2m 2m 2m 2m 2m 2m
ENSYSCE BIO (ENSC)
NASDAQ
$0.28+$0.003 (+0.91%)
Price as of Jul 14, 2026 6:43 AM EDT- $4.2MMarket Cap
- -87.48%1-Year Change
- BiotechnologyIndustry
ENSYSCE BIO (ENSC)
$0.28+$0.003 (+0.91%)
ENSC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.28 | ||
Change | +$0.006 (+2.07%) | ||
Open | $0.27 | ||
High | $0.28 | ||
Low | $0.27 | ||
Previous Close | $0.27 | ||
Volume | 244,373 | ||
30-Day Average Volume | 802,702 | ||
1-Week Change | -6.55% | ||
1-Month Change | 9.67% | ||
1-Year Change | -87.48% | ||
3-Year Change | -99.03% | ||
5-Year Change | -100.00% | ||
Fundamentals | |||
Shares Outstanding | 15.4M | ||
Total Assets | $2.2M | ||
Market Cap | $4.2M | ||
Enterprise Value | $4.0M | ||
Period: QTR TTM FY | |||
Revenue | $960,999.00 | ||
Net Income | -$3.6M | ||
Free Cash Flow | -$3.5M | ||
EBIT | -$3.6M | ||
EBITDA | -$3.5M | ||
Net Working Capital | -$828,275.00 | ||
EPS | -$0.52 | ||
Enterprise Value/EBITDA | -1 | ||
Enterprise Value/Revenue | 4 | ||
P/B | -12 | ||
P/E | -1 | ||
PEG | -0 | ||
Price/Free Cash Flow | -1 | ||
Price/Operating Cash Flow | -1 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 15 | ||
Last Split Date | 12/06/2024 | ||
Earnings & Revenue